Institute of Biomedical Research Corp.
MRESOTCHealthcare● Active
$0.00
+$0.00(+15.38%)
Market Cap$4056731
P/E Ratio—
52W High$0.0197
52W Low$0.0007
Institute of Biomedical Research Corp. (MRES) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MRES · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $0.05M | $0.03M | $0.00M | $0.00M |
| Cost of Revenue | $0.03M | $0.04M | $0.02M | $0.00M | $0.00M |
| Gross Profit | $0.02M | $0.01M | $0.01M | $0.00M | $0.00M |
| Gross Margin %(computed) | 43.25% | 18.97% | 29.46% | — | — |
| Operating Expenses | |||||
| R&D Expenses | ($0.11M) | $0.21M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $0.78M | $1.80M | $0.73M | $0.17M | $0.04M |
| Operating Income | ($0.76M) | ($1.80M) | ($0.72M) | ($0.17M) | ($0.04M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.02M | $0.04M | $0.05M | $0.00M | $0.00M |
| Income Before Tax | ($0.74M) | $1.36M | ($0.43M) | ($0.17M) | ($0.04M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.63M) | $1.33M | ($0.43M) | ($0.17M) | ($0.04M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $0.00 | $-0.00 | $-0.00 | $0.00 |
| Wtd Avg Shares | 2663.61M | 2371.42M | 1454.64M | 915.79M | 915.79M |
| EBITDA | ($0.72M) | $1.39M | ($0.38M) | ($0.17M) | ($0.04M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Institute of Biomedical Research Corp. data
About Institute of Biomedical Research Corp. (MRES) Income Statement
Institute of Biomedical Research Corp. (MRES) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MRES reported revenue of $0.00B, gross profit of $0.00B (gross margin 43.25%), and net income of ($0.00B) — a net profit margin of -1278.56%.
Frequently asked questions
MRES · 4 questionsInstitute of Biomedical Research Corp. (MRES) reported revenue of $0.00B for 2025, up 9.8% year-over-year.
MRES revenueMRES salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09